The invention relates to novel azacarbonlines having formula (I), wherein: R3, R4 represent independently H； hal； CF3； substituted oxy, optionally substituted alkoxy； optionally substituted amino； substituted carbonyl； optionally substituted carboxyl； optionally substituted amide； sulphur, such as optionally substituted sulphones, sulphoxides or sulphides； linear, branched or cyclic C1-C10 alkyl optionally comprising an optionally substituted heteroatom； optionally substituted linear, branched or cyclic C2-C7 alkenyl； optionally substituted linear or branched C2-C6 alkynyl； optionally substituted aryl or heteroaryl； of which may be optionally substituted； in the form of a base or an acid addition salt. The invention also relates to the use of same in therapeutics for the treatment of cancer and to synthesis methods.
